Ulisse Biomed Spa
MIL:UBM
Ulisse Biomed Spa
MIL:UBM
Price:
0.78
EUR
-2.26%
Market Cap:
€19.9m
Balance Sheet
Balance Sheet Decomposition
Ulisse Biomed Spa
Ulisse Biomed Spa
Balance Sheet Decomposition is not available for
Ulisse Biomed Spa
Ulisse Biomed Spa
Balance Sheet
Ulisse Biomed Spa
Ulisse Biomed Spa
Currency: EUR
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
1
|
0
|
5
|
4
|
3
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
1
|
0
|
5
|
4
|
3
|
2
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
1
|
1
|
6
|
5
|
7
|
5
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Intangible Assets |
0
|
0
|
1
|
2
|
1
|
22
|
20
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-36%
|
2
+21%
|
8
+329%
|
7
-18%
|
32
+388%
|
27
-15%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
0
|
1
|
0
|
0
|
0
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Liabilities |
1
N/A
|
1
+33%
|
0
-65%
|
1
+149%
|
1
-18%
|
5
+649%
|
4
-23%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
4
|
4
|
5
|
6
|
11
|
17
|
|
| Additional Paid In Capital |
5
|
5
|
5
|
11
|
11
|
37
|
40
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
1
-62%
|
2
+134%
|
7
+365%
|
6
-18%
|
27
+360%
|
24
-13%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-36%
|
2
+21%
|
8
+329%
|
7
-18%
|
32
+388%
|
27
-15%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
8
|
8
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
